Adar Poonawalla's SII aims to have 100m doses of AstraZeneca vaccine ready by December
Published
Serum Institute of India (SII) is ramping up production of AstraZeneca's Covid-19 vaccine, aiming to have 100 million doses ready by December for a vaccination drive that could begin across India that same month, Bloomberg reported.
If final-stage trial data show that AstraZeneca's vaccine candidate is giving effective...